Search Results - "Lee, Sun Ku"
-
1
Population Pharmacokinetics and Pharmacodynamics of Burosumab in Adult and Pediatric Patients With X‐linked Hypophosphatemia
Published in Journal of clinical pharmacology (01-01-2022)“…Burosumab is a fully human monoclonal antibody against fibroblast growth factor 23, which has been approved to treat X‐linked hypophosphatemia (XLH) in adult…”
Get full text
Journal Article -
2
Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease
Published in PloS one (09-11-2017)“…There are no effective treatments or validated clinical response markers in systemic sclerosis (SSc). We assessed imaging biomarkers and performed gene…”
Get full text
Journal Article -
3
The Pharmacokinetics of Triheptanoin and Its Metabolites in Healthy Subjects and Patients With Long‐Chain Fatty Acid Oxidation Disorders
Published in Clinical pharmacology in drug development (01-11-2021)“…Long‐chain fatty acid oxidation disorders (LC‐FAODs) are a group of life‐threatening autosomal recessive disorders caused by defects in nuclear genes encoding…”
Get full text
Journal Article -
4
Population Pharmacokinetics of Heptanoate in Healthy Subjects and Patients With Long‐Chain Fatty Acid Oxidation Disorders Treated With Triheptanoin
Published in Clinical pharmacology in drug development (01-11-2022)“…Triheptanoin is an odd‐carbon, medium‐chain triglyceride consisting of three fatty acids with seven carbons each on a glycerol backbone, indicated for the…”
Get full text
Journal Article -
5
Resting energy expenditure and the clearance of therapeutic proteins in pediatric subjects
Published in Pharmacology (01-01-2014)“…The effect of age on the clearance (CL) of therapeutic proteins has not been explored extensively in pediatric subjects. Recently, resting energy expenditure…”
Get more information
Journal Article -
6
Model‐Informed Approach to Recommend Burosumab Dosing Regimens for Pediatric and Adult Patients With the Ultrarare Disease Tumor‐Induced Osteomalacia
Published in Clinical pharmacology and therapeutics (01-12-2024)“…Burosumab is approved for the treatment of hypophosphatemia in persistent tumor‐induced osteomalacia. This work exemplifies a model‐informed drug development…”
Get full text
Journal Article -
7
Safety, pharmacokinetics, and pharmacodynamics of BMS-986142, a novel reversible BTK inhibitor, in healthy participants
Published in European journal of clinical pharmacology (01-06-2017)“…Purpose BMS-986142 is an oral, small-molecule reversible inhibitor of Bruton’s tyrosine kinase. The main objectives of our phase I studies were to characterize…”
Get full text
Journal Article -
8
Population Pharmacokinetics of the BTK Inhibitor Acalabrutinib and its Active Metabolite in Healthy Volunteers and Patients with B-Cell Malignancies
Published in Clinical pharmacokinetics (01-05-2019)“…Introduction Bruton tyrosine kinase (BTK) is a key component of B-cell receptor signalling, critical for cell proliferation. Acalabrutinib, a selective,…”
Get full text
Journal Article -
9
Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study
Published in The Lancet. Haematology (01-02-2020)“…Chemoimmunotherapy is typically the standard of care for patients with Waldenström macroglobulinemia; however, infectious and hematologic toxic effects are…”
Get full text
Journal Article -
10
A physiologically based pharmacokinetic model for lactational transfer of PCB 153 with or without PCB 126 in mice
Published in Archives of toxicology (01-02-2007)“…Chemical exposure via breast milk is one of the great concerns in public health. Previously, we demonstrated that most body burden of PCB 153 can be…”
Get full text
Journal Article -
11
Advantages of Calcium Green-1 over Other Fluorescent Dyes in Measuring Cytosolic Calcium in Platelets
Published in Analytical biochemistry (10-09-1999)“…Fluorescent indicators are widely used in the measurements of cytosolic calcium in many cell types for many purposes because they are relatively easy to use…”
Get full text
Journal Article -
12
Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti‐CD28 Domain Antibody Antagonist in Healthy Subjects
Published in Journal of clinical pharmacology (01-02-2017)“…We report pharmacokinetics, pharmacodynamics, and safety of a novel anti‐CD28 domain antibody antagonist (lulizumab pegol) in healthy subjects following…”
Get full text
Journal Article -
13
The roles of ATP and calcium in morphological changes and cytotoxicity induced by 1,4-benzoquinone in platelets
Published in Biochimica et biophysica acta (15-01-2002)“…To understand the mechanism of 1,4-benzoquinone-induced cytotoxicity in platelets, the roles of ATP and calcium in platelet toxicity and morphological changes…”
Get full text
Journal Article -
14
Comparison of pharmacokinetic interactions and physiologically based pharmacokinetic modeling of PCB 153 and PCB 126 in nonpregnant mice, lactating mice, and suckling pups
Published in Toxicological sciences (2002)“…Polychlorinated biphenyls (PCBs) are ubiquitous environmental contaminants that can induce neurological defects in infants and children via placental and…”
Get full text
Journal Article -
15
Safety and Efficacy of Acalabrutinib Plus Bendamustine and Rituximab (BR) in Patients with Treatment-Naive (TN) or Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL)
Published in Blood (29-11-2018)“…Background: MCL is a subtype of NHL that remains largely incurable with conventional therapies; BR is standard first-line therapy. Acalabrutinib is a potent,…”
Get full text
Journal Article -
16
-
17
-
18
Pharmacokinetic/pharmacodynamic (PK/PD) modeling for the respiratory effect of aminophylline in rats
Published in Journal of pharmacological and toxicological methods (01-09-2009)Get full text
Journal Article -
19
Effect of PCBs on the lactational transfer of methyl mercury in mice: PBPK modeling
Published in Environmental toxicology and pharmacology (01-01-2009)“…Abstract MeHg and PCB exposure to lactating mice were analyzed and a physiologically based pharmacokinetic (PBPK) model was developed to describe the…”
Get full text
Journal Article -
20
An integrative study for developmental neurotoxicities of methylmercury and PCBs: Combination of computational modeling with experimental toxicology
Get full text
Dissertation